Advertisement

Ophtecs eyes simplification of contact lens care with innovative products

  • The company is behind some of the most innovative contact lens care products – such as the pioneering povidone iodine disinfecting systems it developed in 2001

Supported by:Discovery Reports
Reading Time:2 minutes
Why you can trust SCMP
Ophtecs - Joe Yoneda - CEO and president

Country Business Reports interviews and articles by Discovery Reports

Consumers turn to contact lenses for their ready availability, variety of low-cost options, ease of use and the quality-of-life improvement they bring. However, improper handling may negate the benefits and pose health risks such as bacterial keratitis and corneal ulcers. Focusing on eye health and safety, Japanese firm Ophtecs developed top-class contact lens care (CLC) products to simplify wear and care for users.

Advertisement

Ophtecs is the company behind some of the most innovative CLC products – such as the pioneering povidone iodine disinfecting systems it developed in 2001. It operates a state-of-the-art research and development facility to continuously raise the standards of eye care.

Working hand in hand with ophthalmologists and end users, the company gains valuable insights that it incorporates into product development.

Advertisement

“When Ophtecs was established in 1981, the goal was to provide the best CLC solutions for the Japanese market. Our corporate culture was to quickly adapt and develop unique products to meet market needs,” says CEO and president Joe Yoneda.

Ophtecs is the only contact lens care solution maker to use povidone iodine for its products. Maximising the wide antibacterial spectrum and safety profile of povidone iodine, Ophtecs developed cleadew, a high-end povidone-iodine-based advanced disinfecting system for contact lenses. Users of speciality contact lens and eye professionals choose cleadew for its strong disinfection efficacy against bacteria, fungi and viruses.

Advertisement